29609-33-4

Basic information

• Product Name: 1-Piperazinesulfonamide, 4-phenyl-
• CAS NO: 29609-33-4
• Molecular Formula: C10H15N3O2S
• Molecular Weight: 241.314
• Mol File: 29609-33-4.mol

Chemical Properties

• CAS DataBase Reference: 1-Piperazinesulfonamide, 4-phenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Piperazinesulfonamide, 4-phenyl-(29609-33-4)
• EPA Substance Registry System: 1-Piperazinesulfonamide, 4-phenyl-(29609-33-4)

Safety Data

• Hazardous Substances Data: 29609-33-4(Hazardous Substances Data)

Upstream product

• 908296-84-4 C₁₅H₂₃N₃O₄S 
• 92-54-6 4-phenyl-1-piperazine 

Relevant articles and documents

Synthesis and antitumor evaluation of novel sulfonylcycloureas derived from nitrogen mustard

A new series of sulfonylcycloureas derivatives have been synthesized and evaluated in vitro for their antitumor activity against four cancer cell lines (A431, Jurkat, U266, and K562). These compounds were prepared by the condensation of several sulfonamides (2am) with ethyl bis(2-chloroethyl)carbamate (1a). The relative cytotoxicity of these new derivatives in comparison to chlorambucil is reported.

Simple, rapid, and clean condensation of sulfonamide and maleic anhydride derivatives: Synthesis of novel 1H- Pyrrole-2,5-diones under heterogeneous conditions

H6P2W18O62is used as an efficient catalyst for the synthesis of novel N-substituted sulfonyl maleimides (1H-Pyrrole-2,5-diones) via the condensation of sulfonamide and maleic anhydride derivatives. The Dawson heteropolyacid was used with a catalytic amount of 2?mmol% in acetonitrile at reflux. The reuse of H6P2W18O62as heterogeneous catalyst several times without decrease in their activity, short reaction times, easy isolation of desired products with good to excellent yields shows the advantages of this novel methodology.

Synthesis of new substituted N-sulfonyl pyrrolidine-2,5-dione using dawson-type heteropolyacid as catalyst

The synthesis of new series of pyrrolidine-2,5-diones having sulfonamide moieties is described. These compounds are synthesized in good yield in three steps (carbamoylation-sulfamoylation, deprotection and condensation) using a catalytic amount of H6P2W18O62 in acetonitrile under refluxing conditions.

Pharmaceutical composition containing N-sulfamoyl-N'-arylpiperazines for the treatment or inhibition of obesity and related conditions

The present invention relates to the use of known and novel N-sulfamoyl-N′-arylpiperazines corresponding to Formula I and their physiologically compatible acid addition salts for the treatment or inhibition of obesity and related conditions.